Dementia is a widely researched brain condition. The risk of developing brain disorders under the umbrella of dementia increases when a patient is clinically diagnosed with noticeable and declined intellectual abilities and mild cognitive impairment. However, research has not yet come up with a reliable way to know which patients with mild cognitive disorders progress to full clinical dementia.
Right now, research firms are coming up with the idea of funding studies on dementia to find a possible solution to the illness. These organizations are also dedicated to supporting other organizations with similar goals as far as dementia is concerned. There are currently no tangible results on dementia, but experts are hoping to find ways to diagnose dementia and prevent or treat it altogether.
What is key when exploring the epidemic of dementia is that investment in the research of the dynamics as well as the cause of the disease are key to finding a meaningful solution to this ravaging epidemic.
The only challenge that researchers face is inadequate funding. If, at all, they are going to achieve their ultimate goal, then funding is going to be inevitable. This funding will help support research into neurodegenerative diseases, the risk factors involved, plus many other things that involve dementia.
The observed differences between people who score low in cognitive tests and don't develop dementia poses future research questions. Dementia study is also complicated in a way because it largely depends on memory tests. Age, sex, race and education are also factors that can show differences in cognitive memory tests regardless of whether the patients have developed dementia or not.
Future research endeavors will be underpinned on the ultimate goal of enhancing prevention measures, diagnosis, care and treatment of dementia. Previous researches conducted in this domain have also created a drive for discovery science as well as the use of experimental medicine. This can be implemented in the direction of picking up new targets for therapeutic development. Future work in this discipline will involve developing successful or prospectively successful compounds to advanced level trials.
Future research work is expected to take a more open form that allows integration of research endeavors with public service. This is expected to increase public participation in the core of dementia research as a bid to increase awareness on the diseases while underscoring the role that research plays in stepping up to the challenges of dementia.
Current dementia and Alzheimer management don't take into account the different categories of patients. Sometimes every patient has a unique mental condition and that will require custom management. Mental conditions worsen with age. Therefore, patients are not always of the same age and custom dementia management is justified.
Finally, it is said that some Australian researchers found a possible natural remedy for dementia. They discovered a natural substance in the body cells known as "Spermidine" which they say can aid in memory loss, which is a major concern for patients suffering from dementia. The concentration of spermidine decreases as one gets older. Spermidine was administered to specimen of mammals such as rats and mice because they have similar memory functions to human beings. So they're hoping that the results will be transferred to humans someday in the near future.
Right now, research firms are coming up with the idea of funding studies on dementia to find a possible solution to the illness. These organizations are also dedicated to supporting other organizations with similar goals as far as dementia is concerned. There are currently no tangible results on dementia, but experts are hoping to find ways to diagnose dementia and prevent or treat it altogether.
What is key when exploring the epidemic of dementia is that investment in the research of the dynamics as well as the cause of the disease are key to finding a meaningful solution to this ravaging epidemic.
The only challenge that researchers face is inadequate funding. If, at all, they are going to achieve their ultimate goal, then funding is going to be inevitable. This funding will help support research into neurodegenerative diseases, the risk factors involved, plus many other things that involve dementia.
The observed differences between people who score low in cognitive tests and don't develop dementia poses future research questions. Dementia study is also complicated in a way because it largely depends on memory tests. Age, sex, race and education are also factors that can show differences in cognitive memory tests regardless of whether the patients have developed dementia or not.
Future research endeavors will be underpinned on the ultimate goal of enhancing prevention measures, diagnosis, care and treatment of dementia. Previous researches conducted in this domain have also created a drive for discovery science as well as the use of experimental medicine. This can be implemented in the direction of picking up new targets for therapeutic development. Future work in this discipline will involve developing successful or prospectively successful compounds to advanced level trials.
Future research work is expected to take a more open form that allows integration of research endeavors with public service. This is expected to increase public participation in the core of dementia research as a bid to increase awareness on the diseases while underscoring the role that research plays in stepping up to the challenges of dementia.
Current dementia and Alzheimer management don't take into account the different categories of patients. Sometimes every patient has a unique mental condition and that will require custom management. Mental conditions worsen with age. Therefore, patients are not always of the same age and custom dementia management is justified.
Finally, it is said that some Australian researchers found a possible natural remedy for dementia. They discovered a natural substance in the body cells known as "Spermidine" which they say can aid in memory loss, which is a major concern for patients suffering from dementia. The concentration of spermidine decreases as one gets older. Spermidine was administered to specimen of mammals such as rats and mice because they have similar memory functions to human beings. So they're hoping that the results will be transferred to humans someday in the near future.
About the Author:
Learn more about the stages of dementia. Stop by the various dementia stages website where you can find out all about the Future of Dementia and the different available treatments.
No comments:
Post a Comment